Get startedLog in
    Picture of ADC Therapeutics SA logo

    ADCT — ADC Therapeutics SA Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for ADC Therapeutics SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    R2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F10-K10-K10-K
    Standards:
    IFRS
    IFRS
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-246-230-157-240-158
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items63.846.564.635.125.4
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital11.6-26.4-46.645.95.34
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-169-233-138-119-124
    Capital Expenditures-2.81-6.38-0.687-3.22-0.867
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-0.019-0.297———
    Other Investing Cash Flow
    Cash from Investing Activities-2.83-6.67-0.687-3.22-0.867
    Financing Cash Flow Items——-1.31—-1.16
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities495267-0.89773.997.1
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash32427.3-140-47.8-27.7